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Objective: Carotid artery stenting (CAS) is usually performed with femoral access; however, this access may be impeded by
anatomic limitations. Moreover, many embolic events happen during aortic arch catheterization. To overcome these
problems, transcervical access to the carotid artery can be used as an alternative approach for CAS.
Methods: An electronic search of the literature using PubMed was performed. All studies reporting the results of CAS
using the transcervical approach were retrieved and analyzed.
Results: The analysis included 12 studies reporting the results of 739 CAS procedures performed in 722 patients (mean
age, 75.5 years). Of 533 lesions reported, 235 (44%) were symptomatic, with no data regarding symptomatic status
available for 206 lesions. Two techniques were used: direct CAS with transcervical access (ﬁlter protected or unprotected)
in 250 patients and CAS with transcervical access under reversed ﬂow (with arteriovenous shunt in most cases) in 489
patients. Local anesthesia was used in 464 of 739 procedures (63%), and the remaining were performed under general
anesthesia or cervical block. Technical success was 96.3% for 579 procedures with available data (558 successful proce-
dures and 21 failures: inability to cross the lesion, 10; dissection, 5; failure of predilatation, 1; stent thrombosis, 1; patient
agitation, 1; and no data, 3). The incidence of conversion to open repair was 3.0% (20 of 579 procedures: 18 carotid
endarterectomies and two common carotid-internal carotid bypass grafts). Stroke occurred in eight patients (two fatal)
and a fatal myocardial infarction in one patient. The incidence of stroke, myocardial infarction, and death was 1.1%,
0.14%, and 0.41%, respectively. The incidence of stroke was 1.2% (3 of 250) in direct CAS with transcervical access and
1.02% (5 of 489) in CAS under reversed ﬂow (P > .05). Transient ischemic attack occurred in 20 patients (2.7%). Local
complications were encountered in 17 of 579 CAS (2.9%), comprising 15 hematomas and two patients with transient
laryngeal palsy.
Conclusions: CAS with the transcervical approach is a safe procedure with low incidence of stroke and complications. It can
be used as an alternative to femoral access in patients with unfavorable aortoiliac or aortic arch anatomy. (J Vasc Surg
2013;58:1402-7.)Carotid artery stenting (CAS) has been widely accepted Embolic events during CAS are related to aortic arch
as a less invasive technique, particularly for patients with
signiﬁcant comorbidities. Although carotid stents have
undergone many design improvements and embolic
protection devices are routinely used, periprocedural
embolic events remain the Achilles’ heel of the technique.
Data from recent randomized trials and meta-analyses have
shown that CAS with transfemoral access is associated with
an increased rate of periprocedural stroke compared with
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2characteristics. Arch elongation, severe arch atheroma,
proximal common carotid disease, and tortuosity repre-
sent potential causes for embolism.5 Diffusion-weighted
magnetic resonance imaging (DW-MRI) after CAS reveals
the presence of new embolic lesions in up to 70% of
patients.6 The International Carotid Stenting Study
(ICSS) investigators found new MRI cerebral lesions in
50% of patients after CAS compared with 17% after
CEA.7 Many of these embolic events occur during naviga-
tion of tortuous extracranial arteries, particularly in patients
with heavily calciﬁed vessels and type II and III aortic
arches.8
Anatomic limitations may impede transfemoral access
for CAS. Aortoiliac or femoral occlusive disease, previous
aortic, iliac, or femoral vascular operations, and excessive
obesity are among the most common access difﬁculties
encountered in patients scheduled for CAS.
To overcome femoral artery access problems and
the embolic events associated with aortic arch catheteriza-
tion, transcervical access to the common carotid artery
(CCA) can be alternatively used for CAS. To provide an
Table I. Studies reporting the results of direct carotid artery stenting (CAS) with transcervical access
First author/
year
Patients,
No.
Mean
age,
years
CAS,
No. EPD
Technical
success
Complications-
treatment
Neurologic
complications
Deaths,
No.
MI,
No.
FU,
months Outcome
Alexandrescu,34
2006
26 73.7 29 (þ) 28/29 1 inability to
cross the
lesion-CEA
0 0 0 11.6 (3-38) 1 TIA, 4
unrelated
deaths
Feldtman,35
2006
15 NR 15 (þ) 12/15 3 inability to
cross the
lesion-CEA
1 stroke (fatal) 1 0 3-18 3 restenoses,
PTA
Mathieu,19
2009
160 NR 160 50 (þ),
110 ()
NR NR 2 strokes
(1 major-fatal,
1 minor)
1 NR NR NR
13 TIA
Palombo,21
2010
44 72.1 44 (þ) 44/44 0 1 TIA 0 0 NR NR
(), Absent; (þ), present; CEA, carotid endarterectomy; EPD, embolic protection device; FU, follow-up; MI, myocardial infarction; NR, not reported;
PTA, percutaneous transluminal angioplasty; TIA, transient ischemic attack.
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we undertook a literature review to analyze all studies
reporting the results of CAS using the transcervical
approach.
METHODS
All reported cases of CAS performed using transcervical
access were identiﬁed through a systematic MEDLINE
search. The keywords used were “cervical access,” “trans-
cervical access,” “direct puncture,” and “carotid stenting.”
The retrieved articles were also searched for any relevant
references. Only reports written in English and reporting
the results of more than ﬁve patients were included in
the analysis.
Initial database search revealed 94 publications; of
these, 66 articles were irrelevant. Two were review arti-
cles,9,10 one was in Japanese,11 and two reported fewer
than ﬁve patients.12,13 Of the remaining 23 publications, 17
were from the same author or institution.14-30 The study
that was most recent or that reported the largest number
of patients was included in the analysis.17,19,21,23,25,30
Twelve articles were considered.17,19,21,23,25,30-36 The full
texts of these articles were retrieved and reviewed. Data
regarding number of patients, age, and the number of
procedures, symptomatic status, technique used, anes-
thesia, technical success, complications, stroke, myocardial
infarction, death rates, and follow-up were collected.
RESULTS
The analysis included 12 studies in which 722 patients
(mean age, 75.5 years) underwent 739 CAS procedures.
Of 533 lesions reported, 235 (44%) were symptomatic,
with no symptomatic status provided for 206 lesions.
Two techniques were used: direct CAS with transcervical
access and CAS with transcervical access under reversed
ﬂow.
Four studies described the results of direct CAS with
transcervical access in a total of 250 procedures (Table I).
With this technique, access to the CCA is performedwith a small incision and CCA dissection or with percuta-
neous CCA puncture. When the CCA is dissected, a sheath
is inserted 1 cm into the artery, and the protection device,
when applied, is advanced to the internal carotid artery
(ICA). For protection during passage through the lesion,
the CCA can be brieﬂy clamped and blood aspirated
through the sheath.34
In cases of percutaneous CCA puncture, an initial
angiogram is performed through the needle, the carotid
bifurcation is located, and a guidewire is advanced to the
external carotid artery. The sheath is safely introduced
into the CCA, and then the protective device is deployed
beyond the lesion. The procedure is conducted as usual. A
StarClose (Abbott Vascular, Abbott Park, Ill) percutaneous
closure device is used for hemostasis after completion of
CAS.19 These authors recommend starting the procedure
by placing ﬁrst the introducer of the StarClose in which
the regular 6F working introducer is ﬁxed and will serve
for the procedure. This way allows ending the procedure
without placing a new guidewire that recrosses the carotid
stent.19 CAS with direct cervical access was performed
with19,21,34,35 or without an embolic protection device.19
A second technique of transcervical CAS involves the
creation of ﬂow reversal, with an arteriovenous shunt in
most cases. This technique has the advantage of crossing
the lesion under retrograde ﬂow. The most widely used
method is described by Criado et al.15 The CCA is accessed
through a vertical mini-incision (4 cm) at the base of the
neck, controlling the proximal CCA with a Rummel
loop. An arteriovenous ﬁstula is established between
the CCA and the internal jugular vein by placing an 8F 
11-cm Super Arrow-Flex percutaneous introducer sheath
(Arrow International, Reading, Pa) in these vessels and
connecting the introducers with a short (15-cm) segment
of tubing. After occluding the CCA with the Rummel
loop and establishing a carotid artery-jugular vein ﬁstula,
retrograde ﬂow in the ICA is ascertained with ﬂuoroscopy
by injecting a small amount of contrast in the CCA and
immediately opening the ﬁstula, observing contrast ﬂow
Table II. Studies reporting the results of transcervical carotid artery stenting (CAS) under reversed ﬂow
First author/
year
Patients,
No.
Mean age,
years
CAS,
No.
Technical
success
Complications-
treatment
Neurologic
complications Deaths MI
FU,
months Outcome
Chang,31 2004 20 73 21 21/21 0 0 0 12 OK
Lin,32 2005 31 NR 31 28/31 No details-CEA 2 TIA 0 0 NR NR
Pipinos,33 2005 17 NR 17 17/17 - 0 0 0 12 OK
Criado,17 2007 97 72 103 100/103 1 CCA dissection,
1 inability to
cross, 1
agitation-all CEA
2 minor strokes -
2 TIA
0 0 3-40 5 unrelated
deaths,
1 stent
occlusion
4 CCA access site
dissections, 3
resolved after
stent placement,
1 interposition
graft
Christopoulos,23
2011
25 79 25 24/25 1 dissection-CEA 1 TIA 0 0 3-24 OK
Pinter,36 2011 44 71.4 44 42/44 1 dissection, 1
inability to
cross-CEA
0 0 0 - -
Leal,24 2012 31 68.1 31 31/31 0 0 0 23.25 OK
Alvarez,27 2012 212 79.9 219 211/219 4 inability to
cross-CEA
3 strokes, 1 1 18.8 6 16.9 1 stroke
2 CCA
dissections-
CCA-to-ICA
bypass
1 TIA
1 failure of
predilatation-
CEA
1 stent
thrombosis-no
treatment
CCA, Common carotid artery; CEA, carotid endarterectomy; EPD, embolic protection device; FU, follow-up; ICA, internal carotid artery; MI, myocardial
infarction; NR, not reported; TIA, transient ischemic attack.
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posed between the arterial and venous sheaths is sometimes
used to collect embolic debris from the transcarotid
manipulations.31
There are two variations of the technique: the Mini-
mally Invasive Cervical Hybrid Intervention (MICHI)
neuroprotection system (Silk Road Medical Inc, Sunnyvale,
Calif) creates an arteriovenous shunt between the CCA and
the femoral vein together with occlusion of the proximal
CCA. It consists of an 8F transcervical arterial access sheath
with a large-bore Y-arm adapter, a large-bore blood ﬂow
line with a ﬂow controller, and an 8F venous return sheath.
The system’s design allows the circuit to drape down the
patient’s thorax and abdomen and allows a single interven-
tionist to work between midchest and midabdomen away
from the X ray source and image intensiﬁer.36
The second variation, described by Christopoulos
et al,23 implies only cannulation of the CCA and establishes
retrograde ﬂow toward a blood transfusion bag positioned
as low as possible so that the pressure gradient ensures
reverse ICA ﬂow. The patients can be autotransfused after
the procedure.23
Eight studies reporting the results of 489 CAS with
transcervical access under reversed ﬂow are included inthe analysis (Table II). Local anesthesia was used in 464
of 739 (63%) of the procedures, and the remaining proce-
dures were performed under general anesthesia or cervical
block. Eleven of the 489 patients (0.8%) with an arteriove-
nous shunt presented with symptoms of intolerance of ﬂow
reversal.
Technical success was achieved in 96.3% of the proce-
dures with available data (558 of 579). Twenty-one failures
were reported, comprising inability to cross the lesion in
10, CCA dissection in 5, failure of predilatation in 1, stent
thrombosis in 1, and failure to complete the procedure
because of patient agitation in 1, and no data regarding
causes of failure were presented in 3. The incidence of
conversion to open repair was 3.4% (20 of 579 proce-
dures): 18 CEAs and two CCA-ICA bypass grafts were
performed. The ﬁve CCA dissections were treated with
CEA in three patients and with CCA-ICA bypass in two.
An asymptomatic stent thrombosis did not require treat-
ment. Four more dissections occurred; three resolved after
stent placement and one required a CCA interposition
graft. All CCA dissections were described after open access
and creation of ﬂow reversal.
Neurologic assessment was performed by a neurologist
in ﬁve studies, by the treating physician in three studies,
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for three studies. Eight patients sustained a stroke (two
fatal), and one fatal myocardial infarction (MI) occurred.
The incidence of stroke, MI, and death was 1.1%, 0.14%,
and 0.41% respectively. The incidence of stroke was 1.2%
(3 of 250) in direct CAS with transcervical access, and
was 1.02% (5 of 489) in CAS under reversed ﬂow
(P > .05). Transient ischemic attack (TIA) occurred in
20 patients (2.7%). Local complications were encountered
in 17 of 579 CAS procedures (2.9%), including 15 hema-
tomas, four of which required surgical drainage, and two
patients with transient laryngeal palsy. The overall compli-
cations rate was 5.4%, which included stroke, death, MI,
surgical exploration for hematoma, stent placement for
dissection, reconstruction of the CCA, nerve palsy, stent
thrombosis, and technical failure.
Three studies investigated the incidence of new MRI
lesions after transcervical CAS, two after direct transcervical
CAS,21,36 and one after transcervical CAS with ﬂow
reversal.25 The total incidence of new DW-MRI lesions
was 14.4% (14 of 97 patients). The incidence of new
lesions was 15.5% (10 of 66 patients) after direct transcer-
vical CAS and 12.9% (4 of 31 patients) after transcervical
CAS with ﬂow reversal.
Eight studies including 443 patients (460 CAS proce-
dures) reported follow-up data. Patient follow-up was for
3 to 40 months. During this period, stroke occurred in
one patient and a TIA in another. There were nine unre-
lated deaths. One asymptomatic stent occlusion was re-
ported, and three restenoses were treated with repeat
angioplasty.
DISCUSSION
Data from the recently reported randomized trials,
Carotid Revascularization Endarterectomy vs Stent Trial
(CREST) and ICSS, showed that CAS with transfemoral
access is associated with an increased rate of periprocedural
stroke compared with CEA.1,2 The combined stroke,
death, and MI rate was not signiﬁcantly different between
CAS and CEA in the CREST study (5.2% vs 4.5%) but was
signiﬁcantly higher in the CAS group in the ICSS study
(8.5% vs 5.2%).1,2 These large randomized trials and earlier
studies have emphasized the role of a learning curve for the
procedure.1,2,37,38 The technical skill is associated with the
ability to gain access to the carotid lesion and traversing the
aortic arch and the proximal carotid artery. Among the
several anatomic risk predictors for carotid stenting, the
aortic arch emerges as a key anatomic feature.5 Most tech-
nical failures in carotid stenting are related to a complex
aortic arch.5 The most challenging anatomies include
a type III arch, arch elongation, severe arch atheroma,
proximal common carotid disease, and severe tortuosity
of the supra-aortic vessels. These unfavorable anatomies
represent potential causes of embolism in the process of
gaining access to the carotid lesion.
The risk of stroke associated with CAS is evidently
related to embolic events that occur during the intravas-
cular instrumentation of the aortic arch and the supra-aortic vessels. This association has been demonstrated
with transcranial Doppler monitoring.39 DW-MRI after
CAS revealed the presence of new embolic lesions in
a signiﬁcant proportion of patients, reaching up to 70%
in one study.6 The ICSS investigators conducted an MRI
substudy and found new MRI lesions in 50% of patients
after CAS compared with 17% after CEA.7 It seems evident
that CAS leads to embolic brain lesions, which are corre-
lated with aortic arch characteristics. Increased prevalence
of severe aortic arch calciﬁcation and target lesion ulcera-
tion are associated with an increased risk for MRI-
detected embolic events during CAS.40
Faggioli et al8 evaluated the correlation between aortic
arch characteristics and the presence of new MRI brain
lesions after CAS and found that the mean volume of
MRI brain lesions was greater in patients with a difﬁcult
aortic arch, complicated plaques, and tortuosity. This
ﬁnding emphasizes a pathogenetic association between
the presence of protruding or mobile atherosclerotic pla-
ques of the aortic arch and the risk of periprocedural embo-
lization. Consistently with these ﬁndings, the CREST
investigators reported that outcomes after CAS vs CEA
were related to patient age, attributable to increasing risk
for stroke after CAS at older ages.41 Arch calciﬁcation
and target lesion ulceration are more prevalent in octoge-
narians, and this association may explain the increased
risk of CAS in the elderly.41-43
To overcome these problems, transcervical access to
the carotid artery has been proposed as an alternative
approach. The results of this analysis show that transcervi-
cal CAS is a feasible and safe method for carotid revascular-
ization. The technical success rate was 96.3%, and the
incidence of TIA, stroke, and death was 2.7%, 1.1%, and
0.41% respectively. Interestingly, only one MI occurred.
There were no signiﬁcant differences regarding the stroke
and TIA rate between direct transcervical CAS (ﬁlter pro-
tected or unprotected) and transcervical CAS under ﬂow
reversal. Although the comparison with studies and meta-
analyses of CAS with transfemoral access may be biased,
there is evidence that CAS by transcervical access may be
associated with a lower risk for stroke, death, and MI.3 A
recently published meta-analysis including all randomized
controlled trials of transfemoral CAS reported a 6.5% inci-
dence of 30-day stroke or death rate, 7.1% in symptomatic
and 2.3% in asymptomatic patients.4 The incidence of
stroke or death #120 days of randomization in the ICSS
trial was 8.5%,1 whereas in the subgroup analysis of symp-
tomatic patients in the CREST trial, the periprocedural
stroke or death rate was 6.0%.2 However, the analysis of
uncontrolled data compiled in this review article cannot
be compared with the data of large randomized trials.
Avoidance of the arch during CAS by transcervical
access and the use of embolic protection seem to decrease
the microembolic burden of CAS.7,25,36 The total inci-
dence of new DW-MRI lesions in this meta-analysis was
14.4%; however, this was investigated in only three studies.
Embolic events during aortic arch manipulation explain the
contralateral hemispheric lesions found in patients who
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published CEA series and unlike in the transfemoral CAS
group, no contralateral hemispheric infarcts were found
in the transcervical cohort.21,25 Two studies compared
the incidence of brain DW-MRI lesions between transfe-
moral and transcervical CAS, and in both studies, the inci-
dence of new lesions was signiﬁcantly lower in the
transcervical CAS group.21,25 Results regarding neurologic
complicationsdeven asymptomaticdmake this technique
safe, although CEA continues to be the gold standard
treatment of carotid artery stenosis in most patients.
Complications after transcervical CAS raise a major
concern because the CCA is close to signiﬁcant anatomic
structures and because the access site is near the target
ICA lesion. Carotid artery dissections caused by the intro-
ducer sheath, cranial nerve injury due to the local anes-
thesia, and local hematomas that may require drainage
are some of the most frequently encountered complica-
tions. Our review analysis identiﬁed three dissections
(0.5%) that resolved after stent placement and ﬁve CCA
dissections (0.9%) that required open reconstructions.
Open reconstructions for CCA dissection included CEA
(n ¼ 3), CCA-ICA bypass graft (n ¼ 2), and CCA interpo-
sition graft (n ¼ 1). Interestingly, no patient experienced
neurologic complications after open reconstruction of
a CCA dissection.17,30,36 Local complications were
encountered in 2.9% of the patients, including 15 hema-
tomas and two nerve injuries due to impregnation of the
nerve with local anesthesia. Only a small proportion of
the cervical hematomas required surgical drainage.
Finally, a small number of patients may not tolerate
ﬂow reversal. In such cases, the procedure can be
completed with antegrade ﬂow without protection or
with intermittent rather than continuous carotid ﬂow
reversal, allowing antegrade cerebral ﬂow in between
carotid instrumentation maneuvers.17,30,36 The last option
in patients with reverse ﬂow intolerance during transcervi-
cal CAS is conversion to CEA.17
CONCLUSIONS
CAS through a transcervical approach is a safe proce-
dure with a very low incidence of stroke and complications.
Two techniques are described in the literature: direct CAS
with transcervical access and transcervical CAS under
reversed ﬂow. There are no signiﬁcant differences
regarding neurologic complications between the two tech-
niques. Transcervical CAS can be used as an alternative to
transfemoral CAS in patients with unfavorable aortoiliac or
aortic arch anatomy.AUTHOR CONTRIBUTIONS
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